NCT04580303View on ClinicalTrials.gov

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

September 24, 2021

Conditions
Edematous Fibrosclerotic PanniculopathyCelluliteLaxity; Skin
Interventions
DRUG

collagenase clostridium histolyticum

Delivered via uniform grid injection techniques.

Trial Locations (3)

10021

Endo Clinical Trial Site #1, New York

33146

Endo Clinical Trial Site #3, Coral Gables

70006

Endo Clinical Trial Site #2, Metairie

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY